TPR series to focus on CTRC clinical trials
Texas Public Radio and the Health Science Center’s Cancer Therapy & Research Center will present the next Think Health Science: Clinical Trials at the Cancer Therapy & Research Center, at 7 p.m., Wednesday, March 9, at Pestana Lecture Hall. The speaker will be Andrew Brenner, M.D., Ph.D.
A group of researchers at the Health Science Center have developed a way to deliver nanoparticle radiation directly to the brain tumor and keep it there. The method doses the tumor itself with much higher levels of radiation, 20 to 30 times the current dose of radiation therapy to patients, but spares a much greater area of brain tissue.
Dr. Brenner is a specialist in both breast cancer and malignancies of the brain and spinal cord. He focuses not only on clinical management, but also on the development of novel therapies to treat these cancers. At the CTRC, he is extensively involved in clinical trials that make new treatments available to South Texas patients. This included a first-in-man study of a new radiation treatment implanted in the center of a patient’s brain tumor called a glioblastoma.
Dr. Brenner earned his bachelor’s degree in biochemistry at Texas A&M University and went on to earn his doctorate in biological science and tumor biology at The University of Texas M.D. Anderson Cancer Center – Science Park. Dr. Brenner received his medical degree from the Texas Tech University Health Sciences Center and completed a residency in internal medicine at Scott and White Hospital in Lubbock. He completed his fellowship in hematology and medical oncology at the UT Health Science Center.
The Think Health Science presentation is free and open to the public.